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Expression and Extracellular  Release of Transferrin  Receptors  During 
Peripheral  Erythroid  Progenitor  Cell  Differentiation  in  Liquid  Culture 
By  Naoaki Shintani, Yutaka  Kohgo, Junji Kato, Hitoshi Kondo, Kohshi Fujikawa, Etsu Miyazaki, and Yoshiro Niitsu 
The  expression  and  extracellular  release  of transferrin re- 
ceptor  (TR) was  investigated by in vitro model  system  of 
erythroid  differentiation.  Human  peripheral  blood  mononu- 
clear  cells  were cultured with interleukin-3 (IL-3) for 7 
days,  and  with erythropoietin (EPO) for an additional 8 
days. After EPO stimulation,  IL-3-stimulated blastic cells 
were  serially  differentiated  into mature erythrocytes.  [3H]- 
thymidine  incorporation  of cultured  cells  increased  linearly 
from day 0 to 5, followed by a decrease. Flow cytometric 
analysis  showed  an  increase  of TR  expression from day 0 
to 5, followed by a slight decrease. By metabolic  labeling 
with [36S]methionine  and  immunoprecipitation,  the cell ly- 
sate  exhibited  a  95-kD  band  corresponding  to  the intact TR 
on  sodium  dodecyl  sulfate-polyacrylamide  gel electropho- 
resis/autoradiography at  day  5,  when  polychromatic  eryth- 
roblasts  had  their peak.  The  culture  supernatant  solubilized 
by tween-20 exhibited  a  95-kD  and  an  85-kD band  on  days 
RANSFERRIN  receptor (TR) is a cell-surface glyco- 
protein that binds to diferric transferrin and is endo- 
cytosed for  intracellular  uptake of inorganic  iron.' The re- 
ceptor  is found  to be  hyperexpressed  on  the  surface of 
rapidly growing cells or erythroid cells for cell proliferation 
or hemoglobin (Hb) synthesis.24 Receptor synthesis is usu- 
ally regulated by  intracellular  iron,  which  interacts with 
iron-responsive element-binding  protein  (IRE-BP).5-6  We 
have shown that immunoreactive TR was detected in the 
circulation7  and postulated that  the  concentration of soluble 
receptor in  serum  reflected the mass of erythropoiesis.' This 
assumption was confirmed by comparing  serum  receptor 
levels with ferrokinetics and body  iron stores.'-"  Recently, 
human serum TR was isolated as a truncated  monomer 
form of tissue receptor."  However, there still remain  some 
controversies  regarding the source and releasing mecha- 
nisms of serum TR.  In  sheep or rat reticulocytes, which re- 
flect the terminal phase of erythroid maturation,  the  intact 
TR was exocytosed in the vesicular  Some cell lines 
such as K562 cells and  HL60 cells, both of which express 
TR highly, externalize the immunoreactive receptors both 
in an intact vesicular and in a truncated  Serum 
TR level  is reduced to a significant degree in patients with 
erythroid hypoplasia and is elevated in  those  with erythroid 
hyperplasia as compared with normal subjects.'"'  In hu- 
man bone  marrow (BM) erythroblasts, TR expression ana- 
lyzed  by  flow cytometry was maximum during the early to 
middle maturation  Therefore, it is possible that 
serum TR is derived from differentiating erythroblasts less 
mature  than  reticulocytes. 
The  aim  of this  report  is to investigate how the  TR  and  its 
mRNA are expressed through the erythroid differentiation 
process and whether soluble receptor  is actually  derived 
from  less mature erythroid  cells than reticulocytes.  The 
analyses were performed using an  in  vitro liquid-culture sys- 
tem that closely models the process of human erythroid 
differentiation.22 
T 
MATERIALS  AND  METHODS 
Human  subjects.  Three hundred milliliters  of  peripheral  blood 
(PB)  was drawn by routine venipuncture from  healthy  adult donors 
who  had  given  written informed consent. 
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5  and 8,  which corresponded to the intact and the trun- 
cated  forms of TR,  respectively.  The  95-kD band was more 
intense at day 5 than at day 8.  The  reverse  transcriptase- 
polymerase  chain  reaction  assay  showed  that the receptor- 
mRNA  expression  was parallel  to  receptor  synthesis.  Thus, 
the synthesis  and  expression  of  TR  on  erythrocytes  is  asso- 
ciated  mainly  with cell proliferation  in the early  phase,  and 
with both cell proliferation and  hemoglobin  production in 
the middle to late phases of maturation.  Concomitantly, 
the extracellular release of TR  from erythrocytes  occurs  in 
the middle to late phases of maturation. These  data  sug- 
gest  that polychromatic  erythroblasts  release  soluble  TR  as 
both intact and truncated forms and  may  be  an  important 
source of serum TR  implicated  as  an  index for  erythropoi- 
etic activity in  the marrow. 
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Liquid-culture system.  Normal human PB mononuclear cells 
(PBMCs)  were  isolated  by  Ficoll  400-sodium  diatrizoate (Phar- 
macia  Fine  Chemicals,  Uppsala,  Sweden)  density  centrifugation, 
harvested, and washed  twice in Iscove's modified  Dulbecco's  me- 
dium (IMDM; GIBCO, Grand Island,  NY).  The PBMCs  were cul- 
tured in accordance with the two-phase liquid-culture  system as  re- 
ported by  Wada et  In brief,  cells  were suspended  in  IMDM 
supplemented with  100  U/mL of human recombinant interleukin- 
3 (IL-3; Genzyme CO,  Boston, MA) at a density  of  1 X  IO6 cells/mL 
in  six-well tissue culture plates (Falcon, Oxnard, CA) and cultured 
for 7 days (the first  phase  of  the culture system). At the end of the 
first  phase  culture, total floating  cells  were collected and treated  with 
carbonyl iron to remove monocyte  macrophage^.^^ After the treat- 
ment, nonphagocytic  cells  were  resuspended  in  IMDM  supple- 
mented with 2 U/mL of recombinant erythropoietin (Em,  Kirin 
Brewery CO,  Tokyo, Japan) at a density  of 5 X  IO5 cells/mL in six- 
well tissue culture plates and further cultured for 8 days (the second 
phase ofthe culture system).  All the cultures  were incubated at 37°C 
in a humidified atmosphere containing 5% O2  and 5% COz.  Viable 
cells  were  counted by  trypan blue  dye  exclusion  method.  The 
differential counts were made by  examining the cytospin prepara- 
tions stained with MayGriinwald Giemsa. Hb contents were deter- 
mined by the cyanmethemoglobin  method?' 
In vitro colonyassays.  Methylcellulose  cultures were performed 
in  35-mm nontissue culture dishes  (Falcon)."  Briefly, a I-mL  mix- 
ture of  I  X  IO5 cultured cells, a-minimum essential  medium  (a- 
MEM;  Flow  Laboratories,  North Ryde,  Australia),  30% fetal calf 
serum  (FCS;  Flow  Laboratories),  1% deionized  bovine  serum  albu- 
min  (Sigma  Chemical  CO,  St  Louis,  MO), 0.8% methylcellulose 
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(Katayama  Chemical,  Osaka,  Japan),  5%  phytohemagglutinin- 
stimulated leukocyte conditioned  medium  (PHA-LCM), and 2 U 
of recombinant  EPO was incubated at 37°C in a humidified atmo- 
sphere containing 5% O2  and 5% CO2.  The  culture plates were eval- 
uated under an inverted microscope on day 7 for colony forming 
units-erythroid (CFU-E), and  on  day  14 for burst forming units- 
erythroid (BFU-E). All determinations were made in triplicate. 
['Hlthymidine  uptake assay.  Cells were harvested in  quadru- 
plicate samples in flat-bottom,  96-well microtiter plates (Falcon, 
Oxnard, CA) at a density of  1 X  IO4 cells/200 pL/well in IMDM 
containing 10%  FCS and 7.4 X  MBq of ['Hlthymidine (Amer- 
ican Radiolabeled Chemicals Inc, St Louis, MO). After 4 hours of 
culture, the cells were harvested with an  automatic multiple cell 
harvester (Labo  Mash; Lab0 Science CO, Ltd,  Tokyo, Japan)  onto 
glass fiber papers, and  the radioactivity of the four replicate wells 
was measured with a scintillation counter. 
Immunofluorescence andflow  cytometry.  TR and glycophorin- 
A expressions were analyzed by  flow  cytometry (Ortho Cytoron; 
Ortho  Diagnostic  Systems  Inc,  Raritan,  NJ)  using  fluorescein- 
labeled  (MoAbs)."  Fluorescein  isothiocyanate-conjugated  anti- 
CD71  antibody  (anti-TR  antibody;  OKT9) was purchased  from 
Becton Dickinson Immunocytometry  System, CA, and antiglyco- 
phorin-A antibody, from Immunotech, SA, Marseille, France. 
Immunocytochemicalstaining.  Cells collected by cytospin were 
incubated with anti-CD7 I  antibody. Avidin-conjugated goat anti- 
mouse IgG antibody and biotinylated alkaline  phosphatase  (Vector 
Laboratories, Inc, Buringame, CA) were used for stainingz4 
Metabolic labeling with ['5S]methionine and imrnunoprecipita- 
tion.  The cells were suspended in methionine-free Eagle's MEM 
(Nissui CO,  Tokyo, Japan) supplemented with glutamine (2  mmol/ 
L) and 5% dialyzed FCS at a density of 1 X  IO6 cells/mL, and incu- 
bated for 30 minutes. Then, the cells were further  incubated for 5 
hours with 3.7 MBq/L  X  IO6 cells of [35S]methionine (American 
Radiolabeled Chemicals Inc, St Louis, MO). All the  cultures were 
incubated at 37°C in a humidified atmosphere  containing  5% O2 
and 5% COz.  The  cell suspensions were centrifuged at 300g for 15 
minutes, and  the  supernatant  and  the cell pellets were recovered 
separately. The cells were washed thoroughly with  IO mmol/L 
KP04, 150 mmol/L NaCI, pH 7.4 buffer (phosphate-buffered saline 
[PBS]), immediately resuspended in PBS containing 0. I% triton  X- 
100 and a cocktail of  protease inhibitors  (Protease  inhibitors  set; 
Boehringer Mannheim  Biochemica,  Mannheim,  Germany) con- 
sisting of leupeptin (100  pg/mL),  pepstatin  (50  pg/mL),  EDTA-Na2 
(IO mmol/L), aprotinin (IO pg/mL), antipain-dihydrochloride (50 
pdmL), bestatin (40 pg/mL), phosphoramidon (100 pg/mL), and 
phenylmethylsulfonyl fluoride (1 mmol/L)  at a density of 1 X  lo6 
cells/mL, and disrupted by sonication. After this  treatment,  mem- 
branes were removed by several centrifugations (at 30,OOOg  for 30 
minutes  each)  and, the solubilized cell extract was suspended.  In 
the parallel experiment,  the  culture supernatant was mixed with a 
cocktail  of  protease  inhibitors  containing  0.05%  tween  20  and 
passed through a 0.2-pm Nalgene filter. Samples derived from both 
the cells and the culture  supernatant  were immunoprecipitated with 
OKT9  and  Protein-A Sepharose (Pharmacia  Fine  Chemicals) as  de- 
scribed elsewhereF5  Normal  mouse IgG (Zymed Laboratories Inc, 
San Francisco, CA) was used instead of OKT9 as control. All the 
procedures after metabolic labeling were performed at 4°C. 
Sodium  dodecyl  sulphate-polyacrylamide gel  electrophoresis 
(SDS-PAGE)  and autoradiography.  Immune complexes were an- 
alyzed by SDS-PAGE under  reducing  conditionsF6 The dried gel 
was exposed to Kodak XAR-5 film (Eastman  Kodak,  Rochester, 
NY)  at  -70°C  for IO  to 14 days. 
Densitometricanalysis.  Using the Image software package (Na- 
tional  lnstitutes of  Health  Research  Services Branch,  Bethesda, 
MD), the intensity ofthe bands on  the  autoradiogram ofthe  culture 
supernatant was analyzed by a Macintosh  Centris  650  computer 
(Apple Computer,  Japan, Inc, Tokyo, Japan) equipped with a scan- 
ner  (model  JX-32F3,  SHARP Corp, Osaka, Japan). 
Semiquantification  of  TR  mRNA  by reverse transcriptase-poly- 
merase chain reaction (RT-PCR)  assay.  Total cellular RNA was 
extracted  by  acid  guanidinium  thiocyanate-phenol-chloroform2' 
from the cultured cells. Total cellular RNA extracted from K562 
cells  was  used as a positive control. 
The  oligonucleotide primers were synthesized using a DNA Syn- 
thesizer (Bioresearch, San Rafael, CA). The primers used for RT- 
PCR  reaction  were  TR-I ; 5'-CTATGAGAGGTACAACAGCC, 
beginning at base position 1925 of human TR  cDNA, and TR-2; 5'- 
GTCAATGTCCCAAACGTCAC,  begnning  at  base  position 
2347.28 
RT-PCR was performed in  an  automatic  thennocycler  (Perkin- 
Elmer Cetus, Norwalk, CT). To  determine  the appropriate  condi- 
tion, we isolated total cellular RNA from the cultured cells on  day 
5 after EPO addition and performed  preliminary  titration assays 
with various amounts (0.0002, 0.002, 0.02,0.2,  and 2 pg) of  RNA 
and over various numbers  of cycles (20, 25, 30, and 35 times) of 
PCR.Z9,30  The  amounts  of0.2  pg  oftotal cellular RNA and 30 cycles 
of PCR were chosen for further assays because the signals obtained 
by the  titration  assays clearly reflected the amounts of RNA loaded. 
In brief, 2 pL each of RNA solution  containing  0.2 pg of total 
cellular  RNA  was dispensed  in a final volume  of 20 pL of  100 
mmol/L Tris/HCI,  pH 8.3,  IO mmol/L MgCI2, 50 mmol/L  KCI, 
and  IO mmol/L  dithiothreitol  containing  300  ng  of  the  TR-2 
primer,  I  mmol/L deoxyribonucleotide  triphosphate,  20 U ofavian 
myeloblastosis virus reverse transcriptase (US Biochemicals, Cleve- 
land, OH), and 20 U of RNasin  (Promega,  Madison,  WI). The mix- 
ture was incubated at 37°C for YO minutes. The resulting DNA tem- 
plates were resuspended in 80 pL  of  100 mmol/L Tris/HCl, pH 
8.3,  IO mmol/L MgClz, 50 mmol/L KCl, 0.01% (wt/vol) gelatin 
containing 300 ng of  the  TR-I primer,  1 mmol/L  dNTP,  and  2.5 U 
of Taq polymerase (Perkin-Elmer  Cetus, Norwalk, CT). PCR (de- 
naturation at 94°C for  l  minute,  annealing  at 55°C for 2 minutes 
and extension at 72°C for  1.5 minutes) was then performed for 30 
cycles. 
After RT-PCR was completed, IO  pL  of each of the reaction mix- 
tures was electrophoresed in a  1 S%  agarose gel (Pharmacia  Fine 
Chemicals) in 1 X TBE buffer.'"  After gel electrophoresis, the  prod- 
ucts were transferred  onto a Nytran  membrane (Schleicher and 
Schuell, Keen, NH) by vacuum  blotting  and hybridized with S'end- 
labeled primer TR-  I  with y32P-adenosine triphosphate (ATP).29 
Autoradiography  of the dried gel was performed  using a Kodak 
XAR-5 film with exposure at -70°C  for 24 hours. 
RESULTS 
Proliferation  and  dlferentiation  of  erythroid  progenitor 
cells in a liquid-culture  system.  Table 1 shows the serial 
changes  in  cell  number,  differential counts,  BFU-E  and 
CFU-E, [3H]thymidine incorporation, glycophorin-A  ex- 
pression, and Hb concentration of cultured cells days after 
EPO stimulation. The blasts  grown  by  IL-3 were  further 
proliferated  and  differentiated  into  erythroid  cells  by 
EPO addition. The cell number started to increase immedi- 
ately and reached a plateau on day 5 after EPO addition. 
Immature  erythroblasts  (basophilic  and  polychromatic 
erythroblasts),  mature erythroblasts (orthochromatic eryth- 
roblasts), and denucleated erythrocytes (reticulocytes)  ap- 
peared  serially after EPO stimulation. The ratio of the ma- 
ture cells  increased  with  incubation time. The sequential 
morphologic changes of  cells  were  essentially  similar to 
those  noted  by  the  previous report.22 The colony assay 
showed BFU-E colony at maximum on day 0, and gradually TRANSFERRIN  RECEPTORS  ON ERYTHROBLASTS  121  1 
Table 1. Serial  Changes  in  Cell Number,  Morphologic Pmfile, BFU-E  and  CFU-E,  [3H]Thyrnidine  Incorporation,  Glycophorin  A  Expression, 
and Hb Concentration on Cultured Cells After Erythropoietin  Addition 
Days After EPO Addition 
0  3  5  8 
Cell  no..  5.0  f  0.0  7.1  f  0.8  10.1 f0.7  10.2t  1 .o 
Morphologic  profilet 
Blastic  cells  98.0  f  0.3  89.5  t  1.5  52.0  f  6.5  9.4f  2.0 
Immature erythroblasts  1.6  f  0.2  9.6  f  1.4  41.2  & 4.5  13.6f  1.6 
Mature erythroblasts  0  0  5.9  & 0.8  59.1  k 3.0 
Denucleated  RBCs  0  0  0.4  f  0.2  17.1  f  1.5 
Myeloid cells  0.4 f  0.1  0.9  f  0.3  0.7  k 0.2  0.8  k 0.2 
No. of  colonies  formed$ 
BFU-E  220  t  20  40  k 20  1022  0 
CFU-E  314  f  40  250  & 50  130  k 40  lo+  l 
I3H]thymidine  incorporation§  678.27  t  53.03  2,914.15f  174.90  5,085.60  f  249.80  3,053.702  188.64 
Glycophorin  A  expression11  0.6  6.0  39.2  66.8 
Hemoglobin  concentration7  0.5  f  0.1  1 .o f  0.2  7.5  k 0.5  15.5  k 0.5 
Abbreviation: RBCs. red blood cells. 
Values represent  the number of  total viable  cells  each day (X 1  05cells/mL; mean t  SD). 
t Values are percentage of differential  counts each day (mean f  SD). Immature erythroblasts  represent basophilic and polychromatic erythroblasts, 
* Values represent  the numbers of BFU-E and CFU-E  colonies  formed by 1  Oe cultured  cells  each day (mean f  SD). 
§ Values represent the radioactivity  of  [3H]thymidine  of  three experiments (cpm/l@ cell; mean f  SD). The radioactivity  of  four replicate  wells was 
11  Values are percentage of positive cells detected by MoAb and flow cytometry each day. 
1  Values are Hb content (pg) per lo6  cultured  cells  detected by cyanmethemoglobin  method each day (mean f  SD). 
and mature erythroblasts  orthochromatic  ones. 
measured  for each experiment. 
decreasing thereafter. CFU-E colony  also  showed  a maxi- 
mum  at  day 0 but its disappearance rate was slower than 
that of  BFU-E. ['Hlthymidine incorporation increased im- 
mediately after EPO stimulation, peaked at day 5  to approx- 
imately 7.5-fold  of  that on day 0 and was  followed  by a de- 
crease on day 8.  The radioactivity  on day 8 was almost equal 
to that on day 3. On  the  other  hand, both the expression 
of glycophorin A and the Hb concentration showed time- 
dependent and consistent increase from day 3. 
Therefore, we chose three sets  of  cultured cells at days 0, 
5,  and 8 for the analysis of TR expression. The cells at day 0 
were mainly made up  of blastic  cells and proerythroblasts 
(the early  phase  of  maturation). Those at day 5  were  rich  in 
immature erythroblasts (the middle phase of maturation). 
The sample from day 8 was rich in mature erythroblasts  and 
denucleated erythrocytes (the terminal phase of  matura- 
tion). 
Expression of TR during erythroid maturation.  The ex- 
pression of TR in  different  phases  of  maturation was stud- 
ied.  As shown  in Fig  1, the percent of  positive  cells  for  sur- 
face TR analyzed by  flow cytometry was 7.3%, 50.1%,  and 
37.9% on days 0, 5, and 8 after EPO stimulation, respec- 
tively.  The maximum expression was  obtained from the 
cells on day 5, a mixture mainly made up of immature 
erythroblasts. We  compared the  results of  May-Giemsa 
staining with those of the immunocytochemical staining of 
TR, cells exhibiting  the maximum expression of TR on day 
5  mainly  consisted  of  polychromatic erythroblasts  as shown 
in Fig 2. 
We labeled cultured cells  with  [35S]methionine  in an at- 
tempt to determine whether this increased receptor expres- 
sion on erythroid cells at the middle maturation phase was 
brought about by the increase  in receptor synthesis.  When 
35S-labeled  TR of the cell  lysate  was  analyzed  by  immuno- 
precipitation using OKT9 and SDS-PAGEfautoradiogra- 
phy, one major band of molecular mass 95-kD, correspond- 
ing to an intact monomer TR, was detected at day 5 (Fig 
3, lane 3), whereas less intense bands corresponding to this 
peptide were detected in samples from days 0 and 8 (Fig 3, 
lanes 2 and 4)  than that from day 5. 
Expression of TR mRNA on cultured cells.  We  used the 
RT-PCR procedure to estimate the receptor-mRNA  expres- 
sion, because the amount of mRNA obtained from donors' 
PBMCs  was too small for the conventional Northern tech- 
nique. 
As shown  in  Fig 4,  a single band of 442 bp, which  was  the 
expected  size  of the deduced TR mRNA, was obtained in 
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Days  after  erythropoietin  addltion 
Fig 1.  Sequential  change  of TR  expression  on  cultured  erythroid 
cells  analyzed  by  flow cytometry  using  anti-TR MoAb, OKTS. 1212  SHlNTANl  ET  AL 
both  K562  cells  (Fig  4, lane I; as a positive control) and the 
cultured cells  (Fig 4, lanes 2 through 4). The intensity was 
maximum at day  5  after EPO addition  (Fig  4,  lane 3), 
whereas  rather  weak at days 0 and 8 (Fig  4, lanes 2 and 4). 
Extracelldar release of TR on cultured cells.  When the 
primary culture supernatant (containing  3SS-labeled  TR re- 
leased  from  cells)  was  solubilized  with  tween  20  and  ana- 
lyzed  by  immunoprecipitation  using  OKT9  and  SDS- 
PAGE/autoradiography as described  before,  two  major 
bands were  observed on days 5 and 8 (Fig 5, lanes 3 and 4) 
that were  not  observed  on  day  0 (Fig 5, lane 2). One was the 
95-kD  band of the intact  monomer TR and the other was 
an  85-kD  band  corresponding  to the truncated form  of TR 
(Fig 5, lanes 3 and 4). The 95-kD  polypeptide  detected  in 
the  culture  supernatant was more  intense  at day 5 than that 
at day 8. We further  compared  the intensity ofthe two  major 
bands on days 5 and 8 by densitometric  scanning;  the rela- 
tive  intensities of 95-kD  and  85-kD  bands  were  2.75 and 
1  .OO  at day 5, respectively,  and  2.28  and  1.68 at day 8, re- 
spectively,  showing  that the  proportion  of the truncated 
form  of solube TR  was  larger  at day 8 than at day 5. There 
were  also  a few lighter  bands  below  the 85-kD  band  on days 
5 and  8,  which  may  represent  degraded  fragments  of TR 
proteins. 
DISCUSSION 
It  is  noted  that erythroid  cells  have a special  requirement 
for  iron  in  the  synthesis  of  Hb  beyond  that for  rapid  expan- 
sion in hematopoietic  progenitor cells. This extraordinary 
requirement is  supplied  by  the rapid  influx of transfemn- 
bound  iron  through  the  surface  TR.'.'" 
Fig 2.  Sequential  morphologic  change  and  im- 
munocytochemical  staining  of TR on  cultured  cells. 
The cultured  cells were stained  by May-Griinwald 
Giemsa  on  day  0 (A), day 5 (B), and  day 8 (C); they 
were also  stained  with anti-TR MoAb (OKT9).  avi- 
din-conjugated  goat-antimouse  IgG  antibody  and 
biotinylated  alkaline  phosphatase  on  day  0 (D), day 
5 (E), and  day  8 (F) after addition of €PO (original 
magnification X 400). 
The present  study  details  the expression  of  TR on ery- 
throid  cells  throughout  their maturation process. To exam- 
ine the expression  of  TR  on  erythroid  progenitor  cells,  flow 
cytometric  analysis  has  been  used.  By flow cytometry,  TR 
was found to be  expressed  highly  on BM erythroid  cells  that 
were sustained  until  a relatively late stage  of maturation as 
compared with  myeloid   cell^.^^.^'  However,  further  bio- 
chemical  and  molecular  biologic  analysis  of  TR  expression 
of  differentiating  erythroid  cells  could  not  be conducted,  be- 
cause  enough  amounts of starting  material  cells  for  such  ex- 
periment were  not  available.  In the  present  experiment,  we 
used  two-phase  liquidculture system to provide a relatively 
homogeneous  population  of  erythroid  cells  with  a sequen- 
tial  differentiation.22  As confirmed by morphologic  exami- 
nation, flow cytometric  analysis  of  glycophorin  A and  deter- 
mination of Hb contents (Table l), this culture system  is a 
considerable  improvement  over  methods  requiring  BM as- 
pirate~~.~~*"  and will be  useful  in  future studies  of these  cells. 
As shown  in  Fig  1,  the cell-surface TR expression was 
rather weak on  the  early  phase  of erythroid maturation,  and 
maximum at the middle  phase; it was  most  numerous on 
polychromatic  erythroblasts  (Fig  2),  and  gradually  de- 
creased  in  the  subsequent  phases  through  the  terminal 
phase. As shown  in  Table  I, both the total viable  cell num- 
ber  and  [3H]thymidine  incorporation  of  cultured  cells in- 
creased  linearly  from  day  0 to  5 after EPO addition,  and Hb 
content showed a rapid  increase  from  day  3. It is  noteworthy 
that the  increase  of  cell-surface  TR  expression  from  day  0 to 
5 (Fig 1) seemed to be biphasic  consisting  of  a gradual in- 
crease  from  day  0 to 3 and a rapid one from  day  3 to 5. Thus, 
it is  suggested  that TR expressed on erythroid cells  might TRANSFERRIN  RECEPTORS  ON  ERYTHROBLASTS  1213 
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Fig  3.  Autoradiograph  of  immunoprecipitates  from  [j6S]- 
methionine-labeled  cell  lysate.  The cultured  cells  were metaboli- 
cally  labeled  with [36S]rnethionine  and  the cell lysate  was immuno- 
precipitated with anti-TR MoAb (OKT9) and  Protein-A  Sepharose. 
The immune  complex  thus  obtained  was analyzed  by  SDS-PAGE 
(1  2.5%)  under  reducing  conditions  and  autoradiography  on  day  0 
(lane 2). day 5 (lane 3).  and  day  8 (lane 4) after EPO addition. In- 
stead of OKT9, normal  mouse  IgG was also  used for immunopre- 
cipitation on  day 5 as a control (lane 1).  Molecular  weight of intact 
monomer  TR  is indicated by an arrow with 95  kD  at  left. 
contribute to the iron  uptake,  mainly  for  their proliferation 
in the early  phase,  and  for  both  cell  proliferation  and Hb 
production in the middle to late  phases  of  erythroid  matu- 
ration. By metabolic  labeling  (Fig  3) and semiquantification 
ofreceptor mRNA (Fig4), it  wasconfirmed  that the increase 
ofreceptor-protein synthesis  as well as receptor  mRNA  give 
rise to the augmented  receptor  expression.  The increase of 
receptor-mRNA  expression  could be explained by  the in- 
creased  transcript  level  of the receptor  gene  and/or stability 
of receptor  mRNA.  Chan  et  a13’  showed  that TR and its 
mRNA are hyperexpressed on chicken embryonic  erythroid 
cells as compared with embryonic fibroblasts, and suggested 
that the receptor  mRNA  expression  is  regulated  to a signifi- 
cant degree at the transcriptional level.  We found that IRE- 
BP  activity  was  increased  and  stabilized  receptor  mRNA 
during the middle  phase  of  erythroid  differentiation  (in 
preparation). 
Recently, we  have  shown that  immunoreactive TR  is 
present in human  serum  and reflects the rate of BM eryth- 
ropoiesi~.~~~  but  there  remain  some  controversies  regarding 
the source and release manner ofsoluble TR from erythroid 
cells.  Beguin et a132.33  reported that the immunoreactive  TR 
in rat and human  serum  is  identical  to the intact receptor of 
the placenta. This is consistent with  previous  reports  that 
sheep or rat  reticulocytes  shed intact  receptor  as a vesicular 
form.’”I6  However,  Shih  et  al pointed out that the main 
compartment  of  TR  in  normal  human  sera  consists  of 
smaller truncated receptors; the intact ones  precipitable  by 
ultracentrifugation is  It  is  also  noted  that 
some cell  lines  such as K562 cells and HL60 cells,  both  of 
which  express  TR  highly,  externalize  the  immunoreac- 
tive  receptors  both  in an  intact  vesicular  and a truncated 
form.’”” Because TR is  expressed  highly  in  erythroblasts  as 
well as in such cultured cell  lines,  it  is  possible that soluble 
TR is  derived  from  differentiating  erythroblasts  less  mature 
than reticulocytes. 
Our findings  provide  the evidence  for  the extracellular re- 
lease  of  TR from  erythroblasts  less mature than reticulo- 
cytes. The culture supernatant of erythroid  cells,  which  was 
solubilized by  Tween-20,  exhibited  two  major  immuno- 
precipitable  bands  of 95-kD  and  85-kD  (Fig  5, lanes 3 and 
4),  corresponding  respectively to the intact  monomer  and 
the truncated form  of  TR.”  It is clear that soluble  receptors 
are actually released  from  erythroid  cells at the middle to 
late  phases  of  maturation as vesicular and/or  truncated 
form,  mainly  from  polychromatic  erythroblasts. Other im- 
portant issues to be resolved are which  phase  of  erythroid 
differentiation  is  responsible  for  the  externalization  of  solu- 
ble TR and how the soluble TR has  appeared. It  was note- 
worthy that the 95-kD  band  was more  intense  at day 5 than 
that at day 8,  whereas the proportion ofthe truncated  form 
of soluble TR was larger at day 8 than at  day 5. There were 
also  some  less intense  immunoprecipitable  bands  ofsmaller 
molecular weights. Taken  together,  it  is  assumed  that the 
synthesis  of intact TR is at a maximum at the middle  phase 
of maturation (day 5) and the truncation of TRs concomi- 
tantly occurs from the middle to late maturation stages by 
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Fig 4.  Southern  blot  analysis  of RT-PCR  products  deduced  from 
TR mRNA on K562 cells  (lane  1) and the cultured  cells  on  day 0 
(lane 2). day 5 (lane 3).  and  day  8 (lane 4)  after €PO addition. 1214 
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Fig 5.  Autoradiograph  of  immunoprecipitates  from released TR 
into  conditioned  medium.  The  cultured  cells were metabolically  la- 
beled with  [36S]methionine  and  the culture supernatant was solu- 
bilized  by 0.05%  Tween 20 and  immunoprecipitated  with  anti-TR 
MoAb  (OKT9)  and Protein-A  Sepharose. The  immune  complex  thus 
obtained was analyzed by SDS-PAGE (1  2.5%)  under reducing con- 
ditions  and  autoradiography on  day  0 (lane 2). day 5 (lane 3). and 
day 8 (lane 4) after EPO addition. Instead of  OKT9,  normal  mouse 
IgG was used for  immunoprecipitation  on day 5 as a control (lane 
1). Molecular weight of  the  truncated form of  TR is indicated by an 
arrow with 85 kD, the intact monomer TR  by an arrow with 95 kD 
at  left, respectively. 
proteolytic cleavage of  the  intact  TRs that  originally  had 
been exocytosed  as  a vesicle (exosome). Our data is compat- 
ible  with  a very recent  report  that  TR of native size appears 
in exosomes before the  truncated  form  of TR is  detected  in 
the  culture  medium  ofsheep   reticulocyte^.^^ When a patient 
with iron deficiency  anemia was  treated  with  intravenous 
iron administration, serum TR level showed a transient rise 
just  after  the  initiation of iron supplementation,  and  then 
returned  to  normal levels with  the  improvement  ofanemia.' 
The reticulocyte  counts  also increased  after  iron supple- 
mentation and  returned  to  normal  levels.  However,  the 
peak  of  reticulocyte  counts  was  observed  two  days  after that 
of serum TR level. If reticulocytes  were  the  main source of 
serum TR,  the  peak of reticulocyte  counts  should  precede 
that of serum TR level. This  discrepancy  could be explained 
by our data,  which  indicate  that  polychromatic  erythro- 
SHlNTANl  ET  AL 
blasts are actually an important source of serum TR; these 
cells will mature  into  reticulocytes  in a few days in BM. 
It still remains to  be  determined  whether  some parts of 
soluble TR  are truly  secretory  forms,  and  how  the  novel 
form of TR36  is responsible for this process. 
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